Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by toinv261on Jan 17, 2022 11:42am
242 Views
Post# 34324614

RE:Brown envelopes

RE:Brown envelopesgeric, IMHO Don hasn't been booted for the following reasons;
  1. Don controls the 3 most powerful positions - COB, CEO and president.
  2. The 2 directors who are protecting their wealth, Hepa and ORI must know Don is incompetent and they have Don right where they want him. They stand to take control of RVX at a very low price possibly.
  3. The other 2 directors will vote the way Don tells them to.
  4. History and friendships.

If you look at Don's decision making history and inability to create shareholder value over the past 11 years it is obvious that Don is completely incompetent.

That being said I have invested a lot of my money into this science so I would really like to be proven wrong.

May is quickly approaching but as one poster pointed out on Agora there in no way that Eastern is going to stand by and let Hepa take control of the IP.

So I think there will be some very interesting events happening soon.
GLTA
Toinv
<< Previous
Bullboard Posts
Next >>